Capricor Therapeutics
CAPR
#8011
Rank
ยฃ0.21 B
Marketcap
ยฃ4.74
Share price
-4.36%
Change (1 day)
-58.44%
Change (1 year)

Earnings for Capricor Therapeutics (CAPR)

Earnings in 2025 (TTM): -ยฃ61.7 Million

According to Capricor Therapeutics 's latest financial reports the company's current earnings are ยฃ11.13 Million. In 2024 the company made an earning of -ยฃ30.15 Million a decrease over its 2023 earnings that were of -ยฃ16.61 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Capricor Therapeutics from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ61.7 Million104.63%
2024 -ยฃ30.15 Million81.57%
2023 -ยฃ16.61 Million-23.2%
2022 -ยฃ21.63 Million44.93%
2021 -ยฃ14.92 Million46.61%
2020 -ยฃ10.18 Million78.71%
2019 -ยฃ5.7 Million-49.7%
2018 -ยฃ11.32 Million-724.78%
2017 ยฃ1.81 M-112.93%
2016 -ยฃ14.02 Million46.27%
2015 -ยฃ9.58 Million106.82%
2014 -ยฃ4.64 Million-48.41%
2013 -ยฃ8.98 Million977.23%
2012 -ยฃ0.84 Million-77.11%
2011 -ยฃ3.65 Million-22.35%
2010 -ยฃ4.69 Million-20.17%
2009 -ยฃ5.88 Million-41.17%
2008 -ยฃ9.99 Million41.05%
2007 -ยฃ7.08 Million1098.87%
2006 -ยฃ0.6 Million4101.55%
2005 -ยฃ0.02 Million-0.97%
2004 -ยฃ0.02 Million17.87%
2003 -ยฃ0.02 Million3.66%
2002 -ยฃ0.02 Million-30.11%
2001 -ยฃ0.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Cytokinetics
CYTK
-ยฃ0.57 Billion 817.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-ยฃ3.58 Million-94.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ24.13 B-39,612.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
ยฃ0.43 B-811.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-ยฃ0.2 Billion 212.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-ยฃ7.07 Million-88.43%๐Ÿ‡บ๐Ÿ‡ธ USA